
Pediatrix Medical (MD) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
458.4M
Gross Profit
102.6M
22.39%
Operating Income
38.7M
8.44%
Net Income
20.7M
4.52%
EPS (Diluted)
$0.24
Balance Sheet Metrics
Total Assets
2.0B
Total Liabilities
1.2B
Shareholders Equity
789.2M
Debt to Equity
1.53
Cash Flow Metrics
Operating Cash Flow
-117.7M
Free Cash Flow
-120.8M
Revenue & Profitability Trend
Pediatrix Medical Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 2.0B | 2.0B | 2.0B | 1.9B | 1.7B |
Cost of Goods Sold | 1.6B | 1.6B | 1.5B | 1.4B | 1.3B |
Gross Profit | 454.3M | 421.6M | 467.0M | 513.2M | 449.3M |
Gross Margin % | 22.6% | 21.1% | 23.7% | 26.9% | 25.9% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 238.4M | 227.5M | 231.4M | 263.4M | 248.9M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 238.4M | 227.5M | 231.4M | 263.4M | 248.9M |
Operating Income | 183.7M | 157.9M | 200.0M | 217.7M | 171.9M |
Operating Margin % | 9.1% | 7.9% | 10.1% | 11.4% | 9.9% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 40.7M | 42.1M | 39.7M | 68.7M | 110.5M |
Other Non-Operating Income | -244.3M | -164.1M | -78.9M | -13.8M | -54.3M |
Pre-tax Income | -101.3M | -48.4M | 81.4M | 135.2M | 7.1M |
Income Tax | -2.3M | 12.0M | 18.8M | 27.2M | 16.7M |
Effective Tax Rate % | 0.0% | 0.0% | 23.1% | 20.1% | 234.0% |
Net Income | -99.1M | -60.4M | 66.3M | 130.9M | -796.5M |
Net Margin % | -4.9% | -3.0% | 3.4% | 6.9% | -45.9% |
Key Metrics | |||||
EBITDA | 218.3M | 196.1M | 237.4M | 251.8M | 202.0M |
EPS (Basic) | $-1.19 | $-0.72 | $0.80 | $1.52 | $-9.31 |
EPS (Diluted) | $-1.19 | $-0.73 | $0.79 | $1.52 | $-9.55 |
Basic Shares Outstanding | 83330000 | 84018023 | 82947000 | 86423000 | 85593000 |
Diluted Shares Outstanding | 83330000 | 84018023 | 82947000 | 86423000 | 85593000 |
Income Statement Trend
Pediatrix Medical Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 229.9M | 73.3M | 9.8M | 387.4M | 1.1B |
Short-term Investments | 118.6M | 104.5M | 93.2M | 99.7M | 104.9M |
Accounts Receivable | 260.0M | 272.3M | 296.8M | 301.8M | 241.9M |
Inventory | - | - | - | - | - |
Other Current Assets | 5.1M | 12.3M | 13.3M | 18.9M | 61.8M |
Total Current Assets | 639.6M | 483.5M | 428.0M | 840.6M | 1.5B |
Non-Current Assets | |||||
Property, Plant & Equipment | 194.6M | 278.3M | 302.1M | 290.0M | 259.0M |
Goodwill | 2.5B | 2.8B | 3.1B | 3.0B | 3.0B |
Intangible Assets | 11.6M | 21.2M | 18.5M | 21.6M | 26.6M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 180.5M | 185.0M | 229.1M | 219.4M | 161.8M |
Total Non-Current Assets | 1.5B | 1.7B | 1.9B | 1.9B | 1.8B |
Total Assets | 2.2B | 2.2B | 2.3B | 2.7B | 3.3B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 46.4M | 34.6M | 31.9M | 36.6M | 59.8M |
Short-term Debt | 33.2M | 36.0M | 36.5M | 22.2M | 21.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 434.1M | 388.9M | 427.0M | 427.4M | 444.3M |
Non-Current Liabilities | |||||
Long-term Debt | 629.1M | 665.7M | 680.6M | 1.0B | 1.8B |
Deferred Tax Liabilities | 34.2M | 34.3M | 33.6M | 41.4M | 61.7M |
Other Non-Current Liabilities | 290.3M | 281.8M | 315.0M | 313.4M | 310.6M |
Total Non-Current Liabilities | 953.7M | 981.8M | 1.0B | 1.4B | 2.2B |
Total Liabilities | 1.4B | 1.4B | 1.5B | 1.8B | 2.6B |
Equity | |||||
Common Stock | 859.0K | 840.0K | 829.0K | 864.0K | 856.0K |
Retained Earnings | -248.5M | -149.5M | -89.1M | -155.4M | -286.4M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 764.9M | 849.1M | 891.6M | 896.7M | 747.7M |
Key Metrics | |||||
Total Debt | 662.3M | 701.6M | 717.1M | 1.1B | 1.8B |
Working Capital | 205.5M | 94.5M | 1.0M | 413.2M | 1.1B |
Balance Sheet Composition
Pediatrix Medical Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -99.1M | -60.4M | 62.6M | 108.0M | -9.6M |
Depreciation & Amortization | 32.2M | 36.2M | 35.6M | 32.1M | 28.4M |
Stock-Based Compensation | 11.9M | 12.3M | 16.1M | 19.0M | 39.0M |
Working Capital Changes | 33.6M | -221.0K | 15.5M | -64.9M | 122.5M |
Operating Cash Flow | -25.5M | -10.8M | 108.9M | 65.0M | 223.6M |
Investing Activities | |||||
Capital Expenditures | -22.0M | -33.3M | -29.7M | -7.5M | -28.8M |
Acquisitions | -8.2M | -6.7M | -28.2M | -29.9M | -2.2M |
Investment Purchases | -64.5M | -31.9M | -17.3M | -35.1M | -61.8M |
Investment Sales | 52.5M | 22.9M | 16.9M | 16.5M | 33.4M |
Investing Cash Flow | -35.4M | -48.2M | -57.0M | -55.4M | -58.3M |
Financing Activities | |||||
Share Repurchases | -1.7M | -919.0K | -88.5M | -4.7M | -8.5M |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 235.5M | 470.0M | 1.5B | 0 | 0 |
Debt Repayment | -250.9M | -489.1M | -1.9B | -762.7M | -528.7M |
Financing Cash Flow | -14.5M | -25.7M | -487.6M | -760.1M | -530.4M |
Free Cash Flow | 184.6M | 104.0M | 137.2M | 44.5M | 175.8M |
Net Change in Cash | -75.4M | -84.7M | -435.6M | -750.6M | -365.1M |
Cash Flow Trend
Pediatrix Medical Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
12.63
Forward P/E
10.73
Price to Book
1.68
Price to Sales
0.74
PEG Ratio
-0.10
Profitability Ratios
Profit Margin
5.66%
Operating Margin
13.59%
Return on Equity
14.27%
Return on Assets
6.50%
Financial Health
Current Ratio
1.80
Debt to Equity
77.91
Beta
1.21
Per Share Data
EPS (TTM)
$1.30
Book Value per Share
$9.79
Revenue per Share
$23.07
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
md | 1.4B | 12.63 | 1.68 | 14.27% | 5.66% | 77.91 |
HCA Healthcare | 94.6B | 16.99 | -77.25 | 13,631.68% | 8.21% | -37.45 |
Tenet Healthcare | 15.7B | 11.15 | 4.18 | 29.65% | 7.18% | 158.70 |
Acadia Healthcare | 2.1B | 14.76 | 0.66 | 4.83% | 4.31% | 74.74 |
Pacs | 1.9B | 19.75 | 3.21 | 110.96% | 2.59% | 469.36 |
Ardent Health | 1.9B | 6.83 | 1.48 | 24.32% | 4.11% | 138.17 |
Financial data is updated regularly. All figures are in the company's reporting currency.